Division of Pediatric Hematology/Oncology

Clinical Trials

Desmoid Tumor

• ARST0321A: Phase II—Study of Sulindac and Tamoxifen in patients with desmoid tumors that are recurrent or not amenable to standard therapy
  Principal investigator: Cindy Schwartz, MD

For more information about these clincial trials and how to participate, please call 401-444-HOPE (4673). For general information about clinical trials please visit the National Cancer Institute.

Back